Article
Prognostic and predictive value of extended RAS mutation and mismatch repair status in stage III colorectal cancer.
Cancer science - 1 Jul 2016
Sasaki Yusuke, Akasu Takayuki, Saito Norio, Kojima Hiroshi, Matsuda Keiji, Nakamori Shoji, Komori Koji, Amagai Kenji, Yamaguchi Tatsuro, Ohue Masayuki, Nagashima Kengo, Yamada Yasuhide
Abstract excerpt
The prognostic and predictive value of KRAS gene mutations in stage III colorectal cancer is controversial because many recent clinical trials have not involved a surgery-alone arm. Additionally, data on the significance of extended RAS (KRAS/NRAS) mutations in stage III cancer are not available. Hence, we undertook a combined analysis of two phase III randomized trials, in which the usefulness of adjuvant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
